Transplant Societies Protest FDA Policy In American Journal Of Transplantation

In an Open Letter to the Federal Drug Administrations (FDA), which appears in the April issue of the American Journal of Transplantation (AJT), the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) explain how FDA policy is thwarting the field of transplant medicine in the United States.